Previous studies indicate that PI3K/AKT signaling pathway activation inhibits osteoblasts [53], NCI-N87 cells [54], CTC-MCC-41 cells, and lung cancer cell apoptosis [55, 56]. The gene discussed is AKT1; the disease is lung carcinoma.